Table 3 Echocardiographic parameters.
From: Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines
Non-PH (n = 21) | Ex-PH (n = 19) | Overt-PH (n = 18) | p value | Non-PH vs Overt-PH | Non-PH vs Ex-PH | Ex-PH vs Overt-PH | |
|---|---|---|---|---|---|---|---|
LVEF, % | 65 ± 4 | 66 ± 5 | 62 ± 9 | 0.132 | |||
LAD, mm | 32 (30–36) | 33 (27–38) | 31 (27–36) | 0.972 | |||
LAVi, mL/m2 | 31 (26–36) | 34 (28–38) | 32 (27–46) | 0.859 | |||
E, cm/s | 67.7 ± 11.1 | 62.1 ± 15.0 | 64.8 ± 18.3 | 0.521 | |||
A, cm/s | 69.7 ± 16.9 | 78.9 ± 14.6 | 76.1 ± 17.8 | 0.233 | |||
E/A | 1.0 (0.8–1.2) | 0.8 (0.7–1.0) | 0.8 (0.7–0.9) | 0.059 | |||
DcT, cm/s | 182 ± 45 | 218 ± 54 | 228 ± 37 | 0.010 | 0.013 | 0.057 | 1.000 |
e’ septal, cm/s | 7.4 ± 2.1 | 6.2 ± 1.7 | 6.0 ± 2.1 | 0.090 | |||
E/e’ septal, cm/s | 9.8 ± 2.8 | 10.5 ± 3.1 | 11.3 ± 3.7 | 0.386 | |||
TVs’, cm/s | 11.7 ± 1.7 | 12.8 ± 2.0 | 12.3 ± 2.1 | 0.244 | |||
TAPSE, mm | 22 ± 3 | 22 ± 3 | 22 ± 4 | 0.913 | |||
RV FAC, % | 41 ± 7 | 43 ± 7 | 38 ± 4 | 0.110 | |||
TAPSE/sPAP, mm/mmHg | 0.73 ± 0.20 | 0.69 ± 0.19 | 0.55 ± 0.15 | 0.018 | 0.019 | 0.857 | 0.095 |